Early research (Phase 1)Study completedNCT07629310What this trial is testingTo Evaluate the Safety of JL18008Who this might be right forHIV Infections Jecho Biopharmaceuticals Co., Ltd. 40
Early research (Phase 1)Study completedNCT00840320What this trial is testingRepeat Dose Safety Study for Compound to Treat AnemiaWho this might be right forKidney Disease GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT03001297What this trial is testingPhase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884Who this might be right forHealthy Volunteers MedImmune LLC 64
Early research (Phase 1)Study completedNCT02524782What this trial is testingA Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 DiabetesWho this might be right forType 2 Diabetes MedImmune LLC 103
Large-scale testing (Phase 3)Looking for participantsNCT06055959What this trial is testingEvaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis UCB Biopharma SRL 8
Large-scale testing (Phase 3)Looking for participantsNCT07557420What this trial is testingEfficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)Who this might be right forNMOSDNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Looking for participantsNCT06546670What this trial is testingA Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell DiseaseWho this might be right forSickle Cell Disease Novartis Pharmaceuticals 161
Early research (Phase 1)Ended earlyNCT04691375What this trial is testingPY314 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorGynecologic CancerBreast Cancer+6 more Ikena Oncology 86
Early research (Phase 1)Study completedNCT00946257What this trial is testingSubcutaneous Administration of Otelixizumab to T1DM PatientsWho this might be right forDiabetes Mellitus, Type 1 GlaxoSmithKline 33
Early research (Phase 1)Study completedNCT05795192What this trial is testingSB17170 Phase1 Trial in Healthy VolunteerWho this might be right forSafety IssuesTolerabilityPharmacokinetics+1 more SPARK Biopharma 64
Testing effectiveness (Phase 2)Study completedNCT04497116What this trial is testingStudy of RP-3500, Camonsertib, in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Repare Therapeutics 276
Early research (Phase 1)Study completedNCT01549106What this trial is testingIPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction StudyWho this might be right forHealthy Volunteers SecuraBio 106
Testing effectiveness (Phase 2)Study completedNCT06471530What this trial is testingInvestigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without DiabetesWho this might be right forOverweight and Obesity Immunwork, Inc. 38
Testing effectiveness (Phase 2)Looking for participantsNCT07646587What this trial is testingWIN378 in Participants With Moderate to Severe COPD (Sirius)Who this might be right forCOPD (Chronic Obstructive Pulmonary Disease) Windward Bio 105
Testing effectiveness (Phase 2)Study completedNCT00392587What this trial is testingInvestigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)Who this might be right forPulmonary Disease, Chronic ObstructiveChronic Obstructive Pulmonary Disease (COPD) GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT01892384What this trial is testingSafety and Tolerability of BI 409306 in Patients With SchizophreniaWho this might be right forSchizophrenia Boehringer Ingelheim 40
Early research (Phase 1)Looking for participantsNCT07760467What this trial is testingTo Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.Who this might be right forParoxysmal Nocturnal Hemoglobinuria, PNH Zhuhai United Laboratories Co., Ltd. 94
Testing effectiveness (Phase 2)Looking for participantsNCT06209736What this trial is testingSafety and Efficacy Study of OMS906 in Patients With C3G and ICGNWho this might be right forC3 GlomerulopathyIdiopathic Immune Complex-Mediated Glomerulonephritis Omeros Corporation 20
Early research (Phase 1)Study completedNCT04007198What this trial is testingItolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled AsthmaWho this might be right forAsthma Biocon Limited 18
Early research (Phase 1)Not Yet RecruitingNCT07813663What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female ParticipantsWho this might be right forHealthy Participants Jazz Pharmaceuticals 188